RBC Capital Reiterates Outperform on Alkermes, Maintains $56 Price Target

Benzinga Newsdesk www.benzinga.com Negative 75.4%

Neg 75.4% Neu 0% Pos 0%

RBC Capital analyst Leonid Timashev reiterates Alkermes (NASDAQ:ALKS) with a Outperform and maintains $56 price target.

Comments

No comments yet. Be the first!